Lymphocyte calcium influx kinetics in multiple sclerosis treated without or with interferon beta

Journal of Neuroimmunology

Volumn 237, Issue 1-2, 2011, Pages 80-86

  Toldi, Gergely ^a,b   Folyovich, András ^c   Simon, Zsuzsa ^c   Zsiga, Katalin ^c   Kaposi, Ambrus ^a,b   Mészáros, Gergo ^a,b   Tulassay, Tivadar ^a,b   Vásárhelyi, Barna ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c ST JOHN'S HOSPITAL   (Hungary)

Author keywords

Calcium influx; IKCa1; Interferon beta; Kv1.3; Multiple sclerosis; T lymphocyte

Indexed keywords

BETA1A INTERFERON; INTERFERON BETA SERINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL IKCA1; POTASSIUM CHANNEL KV1.3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALCIUM TRANSPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TRANSPORT KINETICS;

ADULT; CALCIUM; CALCIUM SIGNALING; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FEMALE; HUMANS; INTERFERON-BETA; KINETICS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PILOT PROJECTS; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS; YOUNG ADULT;

EID: 80051475537     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.06.008     Document Type: Article

References (29)

1. Annunziato F., Galli G., Cosmi L., Romagnani P., Manetti R., Maggi E., et al. Molecules associated with human Th1 or Th2 cells. Eur. Cytokine. Netw. 1998, 9:12-16.
2. Annunziato F., Cosmi L., Galli G., Beltrame C., Romagnani P., Manetti R., et al. Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo. J. Leukoc. Biol. 1999, 65:691-699.
3. Arnason B.G. Interferon beta in multiple sclerosis. Clin. Immunol. Immunopathol. 1996, 81:1-11.
4. Basso A.S., Cheroutre H., Mucida D. More stories on Th17 cells. Cell. Res. 2009, 19:399-411.
5. Beeton C., Wulff H., Standifer N.E., Azam P., Mullen K.M., Pennington M.W., et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:17414-17419.
6. Buntinx M., Ameloot M., Steels P., Janssen P., Medaer R., Geusens P., et al. Interferon-gamma-induced calcium influx in T lymphocytes of multiple sclerosis and rheumatoid arthritis patients: a complementary mechanism for T cell activation?. J. Neuroimmunol. 2002, 124:70-82.
7. Chandy K.G., Wulff H., Beeton C., Pennington M., Gutman G.A., Cahalan M.D. K+ channels as targets for specific immunomodulation. Trends. Pharmacol. Sci. 2004, 25:280-289.
8. Crabtree G.R., Clipstone N.A. Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu. Rev. Biochem. 1994, 63:1045-1083.
9. Fanger C.M., Neben A.L., Cahalan M.D. Differential Ca2+ influx, KCa channel activity, and Ca2+ clearance distinguish Th1 and Th2 lymphocytes. J. Immunol. 2000, 164:1153-1160.
10. Hu L., Pennington M., Jiang Q., Whartenby K.A., Calabresi P.A. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes. J. Immunol. 2007, 179:4563-4570.
11. Huang Y.M., Stoyanova N., Jin Y.P., Teleshova N., Hussien Y., Xiao B.G., et al. Altered phenotype and function of blood dendritic cells in multiple sclerosis are modulated by IFN-beta and IL-10. Clin. Exp. Immunol. 2001, 124:306-314.
12. Kaposi A.S., Veress G., Vásárhelyi B., Macardle P., Bailey S., Tulassay T., et al. Cytometry-acquired calcium-flux data analysis in activated lymphocytes. Cytometry A. 2008, 73:246-253.
13. Martino G., Grohovaz F., Brambilla E., Codazzi F., Consiglio A., Clementi E., et al. Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients. Ann. Neurol. 1998, 43:340-349.
14. Martino G., Furlan R., Brambilla E., Bergami A., Ruffini F., Gironi M., et al. Cytokines and immunity in multiple sclerosis: the dual signal hypothesis. J. Neuroimmunol. 2000, 109:3-9.
15. Matheu M.P., Beeton C., Garcia A., Chi V., Rangaraju S., Safrina O., et al. Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Immunity 2008, 29:602-614.
16. Ozenci V., Kouwenhoven M., Huang Y.M., Kivisäkk P., Link H. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment. Clin. Exp. Immunol. 2000, 120:147-153.
17. Panyi G. Biophysical and pharmacological aspects of K+channels in T lymphocytes. Eur. Biophys. J. 2005, 34:515-529.
18. Panyi G., Possani L.D., Rodríguez de la Vega R.C., Gáspár R., Varga Z. K+channel blockers: novel tools to inhibit T cell activation leading to specific immunosuppression. Curr. Pharm. Des. 2006, 18:2199-2220.
19. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005, 58:840-846.
20. Prat A., Al-Asmi A., Duquette P., Antel J.P. Lymphocyte migration and multiple sclerosis: relation with disease course and therapy. Ann. Neurol. 1999, 46:253-256.
21. Rangaraju S., Chi V., Pennington M.W., Chandy K.G. Kv1.3 potassium channels as a therapeutic target in multiple sclerosis. Expert. Opin. Ther. Targets. 2009, 13:909-924.
22. Rus H., Pardo C.A., Hu L., Darrah E., Cudrici C., Niculescu T., et al. The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:11094-11099.
23. Sibley W.A., Bamford C.R., Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985, 8441:1313-1315.
24. Toldi G., Vásárhelyi B., Kaposi A., Mészáros G., Pánczél P., Hosszufalusi N., et al. Lymphocyte activation in type 1 diabetes mellitus: the increased significance of Kv1.3 potassium channels. Immunol. Lett. 2010, 133:35-41.
25. Varga Z., Csepany T., Papp F., Fabian A., Gogolak P., Toth A., et al. Potassium channel expression in human CD4+ regulatory and naïve T cells from healthy subjects and multiple sclerosis patients. Immunol. Lett. 2009, 124:95-101.
26. Verheugen J.A., Vijverberg H.P. Intracellular Ca2+ oscillations and membrane potential fluctuations in intact human T lymphocytes: role of K+channels in Ca2+ signaling. Cell Calcium. 1995, 17:287-300.
27. Wulff H., Calabresi P.A., Allie R., Yun S., Pennington M., Beeton C., et al. The voltage-gated Kv1.3K+channel in effector memory T cells as new target for MS. J. Clin. Invest. 2003, 111:1703-1713.
28. Yamamoto J., Adachi Y., Onoue Y., Adachi Y.S., Okabe Y., Itazawa T., et al. Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells. J. Leukoc. Biol. 2000, 68:568-574.
29. Zang Y., Hong J., Robinson R., Li S., Rivera V.M., Zhang J.Z. Immune regulatory properties and interactions of copolymer-I and beta-interferon 1a in multiple sclerosis. J. Neuroimmunol. 2003, 137:144-153.